Vitamin D status among long-term survivors of hematopoietic cell transplantation.
Vitamin D status among long-term survivors of hematopoietic cell transplantation.
复制标题
造血细胞移植长期幸存者的维生素 D 状况。
DOI:
10.1038/bmt.2010.326
复制
发表时间:
2011
影响因子:
4.8
通讯作者:
Burns,LJ
中科院分区:
文献类型:
--
作者:
Robien,K;Strayer,LG;Majhail,N;Lazovich,D;Baker,KS;Smith,AR;Mulrooney,DA;Burns,LJ
Little is known about serum vitamin D levels following hematopoietic cell transplantation (HCT). Patients are instructed to avoid sun exposure because of an increased risk of skin cancers. Altered gastrointestinal absorptive capacity as a result of GVHD, bile acid or pancreatic enzyme insufficiency or bacterial overgrowth may lead to difficulty in absorbing the fat-soluble vitamin D. This study was undertaken to determine the prevalence of serum 25-hydroxyvitamin D (25 (OH) D) deficiency, and factors associated with 25 (OH) D deficiency, among children and adults who were at least 1 year following HCT. A total of 95 participants (54 males and 41 females) completed a questionnaire on usual diet and lifestyle, and provided a blood sample for 25 (OH) D determinations between November 2008 and July 2009. The majority of participants had serum 25 (OH) D levels⩾ 75 nmol/L (n= 62, 65%), 23 had insufficient levels (50–75 nmol/L) and 10 participants were deficient (< 50 nmol/L). The majority of participants reported regular use of vitamin D supplements (n= 58, 61%). Prednisone use was significantly inversely associated with serum 25 (OH) D concentrations. Total vitamin D intake was the strongest single predictor of 25 (OH) D concentrations. These findings suggest that 400–600 IU vitamin D per day appears to be required to achieve optimal serum 25 (OH) D concentrations following HCT.